Diabetes

Consumer Advocacy Group Wants SGLT-2 Warnings for Type 1 Patients

Consumer Advocacy Group Wants SGLT-2 Warnings for Type 1 Patients

Public Citizen, a consumer advocacy group, is urging the FDA to strengthen its warnings that SGLT-2 inhibitors are associated with increased risk of diabetic ketoacidosis, due to hundreds of cases of this potentially fatal condition in people with type 1 diabetes. SGLT-2 inhibitors are not currently approved for use in type 1 diabetes in the US. Read more


Via Source link

Most Popular

Safety Health News Provides information on HEALTH NEWS, HEALTH CARE, WOMEN’S HEALTH, KID’S HEALTH, MEN’S HEALTH, DIABETES & DEALS NEWS

All About information only. Please consult your Doctor for any illness.

Copyright © 2020 Safety Health News. Powered by Wordpress.

To Top